In this interview, CEO Bob Rauker and VP of global sales Bob Fary take me through the strong demand and forthcoming launch of Belluscura ’s best-in-class DISCOV-R portable oxygen concentrator.
Alongside providing their latest thoughts on the group's roll-out strategy, production plans, X-PLOR device and proprietary NOMAD biometric app.
Disclosure: Vox markets paid me to interview Belluscura
Stocks owned : EQLS, AGFX, Pfizer, Bristol Myers, Roche, WATR, VCT, MBH, ASTO, IOM, TR25, ESYS, ELCO, IHC, Paypal & AOM Elsewhere, I'm also paid by Vox Markets (as a contractor) to interview interview fund managers, capital market experts & companies (re EQLS, VRCI, BELL, FIN, AVG, AVCT, LLAI, VLG, FADL, SUP, ELCO, LORD , MPAC & ONC). I believe all these stocks are clients of Vox.Lastly my 24 year HIT RATE is only 62%. Meaning 38% of the time I lose money (ie often wrong) - albeit my winners are (on average) 1.5x larger than my losers. Please Do Your Own Research. more »
